Understanding the complex network of factors driving healthcare disparities is paramount to reducing them. Many studies have identified disparities in treatment between Black and White individuals with muscle-invasive bladder cancer (MIBC) but are limited to broad generalizations for entire racial/ethnic groups. Few studies use a conceptual framework that includes other racial/ethnic groups or examines how treatment disparities mediate differences in overall survival both within and between racial/ethnic groups.